Roberto Bianchi
Oprichter bij BMG Pharma SpA
Actieve functies van Roberto Bianchi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | Voorzitter | - | - |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | Directeur/Bestuurslid | 01-01-2011 | - |
Oprichter | 01-01-2011 | - | |
Voorzitter | 01-01-2011 | - |
Loopbaan van Roberto Bianchi
Eerdere bekende functies van Roberto Bianchi
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
TitanMet Private Equity
TitanMet Private Equity Investment ManagersFinance TitanMet SpA Private Equity, is the private equity operating division of Kyklos Spa and it manages the publicly listed investment vehicle TitanMet SpA (BIT:TTT). The firm was previously known as Sintesi Societa' di investmenti e Partecipazioni SpA and was founded in 1900 as Broggi Izar Fabbriche Riunite SpA. The firm is headquarterd in Milan Italy. | Directeur/Bestuurslid | 25-09-2007 | 26-01-2009 |
AQ Tech SpA
AQ Tech SpA Pharmaceuticals: MajorHealth Technology AQ Tech SpA is a new industrial holding company which provides excellent solutions in four main fields: pharmaceuticals, food supplements, dermocosmetics, and medical devices. AQ Tech, exploits the skills of R&D Labs able to turn a simple active principle into a successful solution: Selection, working with Research Centres and Universities, of innovative substances suitable in the field of dermocosmesis and food supplements, research aimed at licensing of substances and formulations and at finding possible fields of application, development of production lines exploiting the synergism between topical application (dermocosmetics) and systemic action (food supplements), and development and application of innovative technologies in production and packaging. AQ Tech makes 2 modern productive set-ups available for partners to warrant the requested timing and quality of production. | Algemeen Directeur | 01-12-2010 | - |
Voorzitter | 05-05-2010 | 01-12-2010 |
Opleiding van Roberto Bianchi
University of Bocconi | Undergraduate Degree |
Statistieken
Internationaal
Italië | 6 |
Operationeel
Chairman | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
AQ Tech SpA
AQ Tech SpA Pharmaceuticals: MajorHealth Technology AQ Tech SpA is a new industrial holding company which provides excellent solutions in four main fields: pharmaceuticals, food supplements, dermocosmetics, and medical devices. AQ Tech, exploits the skills of R&D Labs able to turn a simple active principle into a successful solution: Selection, working with Research Centres and Universities, of innovative substances suitable in the field of dermocosmesis and food supplements, research aimed at licensing of substances and formulations and at finding possible fields of application, development of production lines exploiting the synergism between topical application (dermocosmetics) and systemic action (food supplements), and development and application of innovative technologies in production and packaging. AQ Tech makes 2 modern productive set-ups available for partners to warrant the requested timing and quality of production. | Health Technology |
TitanMet Private Equity
TitanMet Private Equity Investment ManagersFinance TitanMet SpA Private Equity, is the private equity operating division of Kyklos Spa and it manages the publicly listed investment vehicle TitanMet SpA (BIT:TTT). The firm was previously known as Sintesi Societa' di investmenti e Partecipazioni SpA and was founded in 1900 as Broggi Izar Fabbriche Riunite SpA. The firm is headquarterd in Milan Italy. | Finance |
Serichim Srl
Serichim Srl BiotechnologyHealth Technology Serichim Srl engages in research and development of chemical synthesis methods and processes for the production of fine chemical intermediaries. The firm's services include contract research, patent analysis, feasibility studies, consultancy and technical assistance, research and environmental consultancy, fermentation, enzyme fractionation, bioprocess engineering, pilot-scale and industrial processes. The company was founded in 2006 and is headquartered in Torviscosa, Italy. | Health Technology |
BMG Pharma SpA
BMG Pharma SpA Household/Personal CareConsumer Non-Durables BMG Pharma SpA is a pharmaceutical company based in Milan, Italy. The Italian company specializes in the development and international partnership of bio-pharmaceutical products. The company focuses on the progress of oral care, dermatology, and dietary supplements. BMG Pharma is committed to sustainability, diversity, and inclusion in the workplace. BMG Pharma has developed the hyaluromimethic® technology, which they believe is a fundamental value. The company has registered 36 innovative products and launched 37 on the international market. Recently, BMG Pharma has signed an agreement with HTL Biotechnology for the production of the functional ingredient at the base of the patented hyaluromimethic®. The company was founded in 2011 by Marco Mastrodonato and Roberto Bianchi, with Marco Mastrodonato serving as the CEO since then. | Consumer Non-Durables |
- Beurs
- Insiders
- Roberto Bianchi
- Ervaring